Jeff E. Knight insider trades

Open-market stock purchases and sales by Jeff E. Knight, Chief Dev & Operating Officer at ALX Oncology Holdings Inc, from SEC Form 4 filings since Sep 1, 2021.

Recent trades

DateStockTradeValue
Apr 16, 2026ALXO ALX Oncology Holdings IncBought (not open market)—
Apr 8, 2026CRNX Crinetics Pharmaceuticals, IncSold$3.4M
Apr 8, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Apr 8, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Apr 8, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Mar 16, 2026CRNX Crinetics Pharmaceuticals, IncSold$221K
Mar 16, 2026CRNX Crinetics Pharmaceuticals, IncSold$150K
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ALXO ALX Oncology Holdings Inc: other filings, last Apr 16, 2026
  • CRNX Crinetics Pharmaceuticals, Inc: 11 sales, last Apr 8, 2026

Get free alerts when Jeff E. Knight files a new trade →